Tag Archives: Treatment

Viewpoints: The FDA Isn’t Up To The Task Of Reining In The Opioid Epidemic; The Downside Of Taking Children From Parents In Drug Treatment

Editorial writers weigh in on these and other health care topics. The Washington Post: This Is Why The Federal Government Has A Hard Time Regulating Prescription Opioids This past week, President Trump argued on national television that to end the opioid epidemic, Congress needed to fund the building of a wall at the United States’… Read More »

The Treatment Gap: In Rehab, ‘Two Warring Factions’: Abstinence vs. Medication

MURFREESBORO, Tenn. — Just past a cemetery along a country road, an addiction treatment center called JourneyPure at the River draws hundreds of patients a month who are addicted to opioids and other drugs. They divide their days between therapy sessions, songwriting, communing with horses and climbing through a treetop ropes course. After dinner, they’re… Read More »

Benefits of dolutegravir treatment for all substantially outweigh the risks

If people with viral loads above 1000 copies/ml on an existing first-line regimen and women intending to have children were excluded from dolutegravir treatment, only 43% of adults living with HIV would receive dolutegravir over a 20-year period. If only women intending to have children were excluded from dolutegravir treatment, 54% would receive the drug.… Read More »

Public Health England warns that improved treatment and testing rates for STIs in the UK could be imperilled by cuts

The authors place the post-AIDS increase in STIs within a historic context. Gonorrhoea cases in the UK have been recorded since 1918 and syphilis since 1922, when the UK’s network of free and confidential STI clinics was set up. This was after a Royal Commission on Venereal Diseases (as STIs used to be called) recommended… Read More »